Skip to main content
Agios logo Agios logo
  • About Us
    • Values
    • History
    • Leadership
    • Corporate Social Responsibility
    • Access to Medicines
    • News
  • Rare Diseases
    • Pyruvate Kinase Deficiency
    • Thalassemia
    • Sickle Cell Disease
    • Our Science
  • Pipeline
  • Our Medicine
  • Patients & Partners
    • Patients & Caregivers
      • Clinical Trials
      • Patient Resources
    • Healthcare Providers
      • Healthcare Provider Resources
      • Clinical Data Sharing
    • Partner Opportunities
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financials
    • IR Resources
  • Inside Agios
    • Careers
    • Culture
    • Diversity
    • Commitment to Community
    • Benefits

Accessibility Statement

 

 

Why We’re Committed to Digital Accessibility

We believe in equal opportunity and personal independence. We want everyone who visits our websites and other digital offerings to feel welcome and productive. We followed the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards to make this website accessible, usable, and functional for people who are disabled or rely on alternative and assistive technologies. This website utilizes various technologies to make it as accessible as possible. If you have any questions about our website’s accessibility or usability, or thoughts on how to improve them, please share with us at (617) 649-8600.

 

 

 

 

LinkedIn logo
Twitter logo
  • Contact
  • About Us
  • Partner Opportunities
  • Careers
Agios Logo

© 2025

All right reserved.

  • Copyright Info
  • Compliance
  • Accessibility Statement
  • Sitemap
  • Privacy Notice
  • Terms of Use
  • Data Privacy Framework Policy
  • Consumer Health Data Privacy Policy